Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on April 8, 2025
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
GlobeNewswire
·
April 8, 2025
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development …
SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
GlobeNewswire
·
April 8, 2025
JERSEY CITY, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of …
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
GlobeNewswire
·
April 8, 2025
MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company has enrolled 50% of the patients in its ASCEND clinical trial for VIA Disc NPTM. The ASCEND study is a …
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
GlobeNewswire
·
April 8, 2025
Analyses of MRI and VEP data confirm anatomical and physiological improvements, indicating remyelination and neuronal repair in the brains of MS patients treated with CNM-Au8 during the long-term extension of VISIONARY-MS Over 90% of participants who …
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas
GlobeNewswire
·
April 8, 2025
Geneva, Switzerland, April 08, 2025 (GLOBE NEWSWIRE) -- The Financial Market Authority (FMA) in Liechtenstein has approved the security prospectus for OilXCoin for offering in key EEA jurisdictions and establishing its presence in the Real-World Asset (RWA …
XRPTurbo Launches $XRT Token On Bitmart, Set To Release Liquid Staking Platform & Upcoming Launchpad
GlobeNewswire
·
April 8, 2025
TALLINN, Estonia, April 08, 2025 (GLOBE NEWSWIRE) -- XRPTurbo, the first AI …
VR Resources Identifies Geochemical Trends from New Data on Copper-Gold Veins at Silverback Project, Ontario
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the "Company", or “VR”, is pleased to announce new data, and results of a comprehensive geochemical study, at its 100%-owned Silverback …
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
GlobeNewswire
·
April 8, 2025
‒ Q1 2025 Unaudited Net Revenue of $39.0 million ‒ ‒ Expected Q1 Adjusted EBITDA above $22.5 million ‒ ‒ Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million ‒ BERKELEY HEIGHTS, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: …
Robex Announces Settlement Agreement
GlobeNewswire
·
April 8, 2025
QUÉBEC CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (TSXV: RBX) (“Robex” or the “Company”) announces that it has entered into a settlement agreement with certain claimants (the “Claimants”) that were party to a share purchase agreement …
EvolveImmune Therapeutics Announces Translational Research Collaboration to Evaluate Expression of Novel Tumor Target in Muscle-Invasive Bladder Cancer
GlobeNewswire
·
April 8, 2025
BRANFORD, Conn. and NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to current immunotherapies, today announced …
Comanche Biopharma Announces European Medicines Agency (EMA) Has Granted Orphan Drug Designation for CBP-4888 in sFlt1-mediated Preterm Preeclampsia
GlobeNewswire
·
April 8, 2025
EMA orphan drug designation is awarded to drugs intended to treat rare diseases that are life-threatening or chronically debilitating Preeclampsia, a serious obstetric complication, is a leading cause of near-term morbidity and mortality for mothers and …
ECARX Announces Upsizing and Extension of Share Repurchase Program
GlobeNewswire
·
April 8, 2025
SHANGHAI, April 08, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings, Inc. (Nasdaq: ECX) (“ECARX” or “the Company”), a global mobility tech provider, today announced that the Company’s board of directors has approved an additional US$20 million in share repurchase …
Koryx Copper Provides Update on Zambia Projects and Planned 2025 Exploration Work Program
GlobeNewswire
·
April 8, 2025
Highlights Koryx Copper owns 51% of two highly prospective exploration licenses in the Zambian copper belt, with an option to earn up to 80% over the next 30 months. Over the last few months significant work was completed in preparation for the …
Aya Or & Argent publie des résultats de forage à haute teneur à Boumadine, augmente l’étendue de la zone Tizi à 2,2 km et identifie de nouvelles cibles régionales
GlobeNewswire
·
April 8, 2025
MONTRÉAL, 08 avr. 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer de nouveaux résultats de forage d’exploration à haute teneur issus de son programme 2024-2025 à Boumadine dans le …
Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
GlobeNewswire
·
April 8, 2025
Vancouver, Canada, April 08, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Sats Terminal Raises $1.7M to Simplify and Scale Bitcoin DeFi
GlobeNewswire
·
April 8, 2025
Pre-seed round led by Coinbase Ventures and Draper Associates signals growing institutional interest in Bitcoin-native finance. SAN FRANCISCO, April 08, 2025 (GLOBE NEWSWIRE) -- Sats Terminal, the Bitcoin decentralized finance (DeFi) aggregation protocol, …
Yachting: UBS confirms its role as strategic partner of the Yacht Club de Monaco
GlobeNewswire
·
April 8, 2025
MONACO, April 08, 2025 (GLOBE NEWSWIRE) -- The Yacht Club de Monaco and UBS renew a partnership that goes far beyond simple sponsorship. It is a strategic alliance that has its roots in over thirty years of shared history and that today is projected with …
Titan Appoints Kevin Hart as Chief Financial Officer
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX: TI, OTCQB: TIMCF) (“Titan” or the "Company") is pleased to announce the appointment of Mr. Kevin Hart as Chief Financial Officer, effective immediately. Kevin …
Crushon AI Upgrades Spicy AI Chat with Multi-Model NSFW AI
GlobeNewswire
·
April 8, 2025
LOS ANGELES, April 08, 2025 (GLOBE NEWSWIRE) -- Crushon AI is releasing a new version of its conversational platform, cementing its commitment to Spicy AI Free accessibility while continuing to innovate as one of the leading players in the NSFW AI space. …